Marche
Farmeconomia
View Archive InfoField | Value | |
Title |
Marche
|
|
Creator |
Cavallo, Maria Caterina
Cipriani, Filippo Gerzeli, Simone Demarteau, Nadia Marocco, Alessia Bamfi, Francesco |
|
Subject |
Pharmacoeconomics; Health economics
Marche; HPV vaccination; Economic & clinical impact |
|
Description |
In Marche region 65,7% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 26 cases of cervicocarcinoma and 11 related deaths and thus results to be cost-effective (21.677 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 25 cancer cases and 11 deaths could be prevented, with a very similar cost-effectiveness ratio. In Marche region, the net cost for woman vaccinated is 155 € for the single cohort and 158 € for the multiple cohort.
|
|
Publisher |
SEEd
|
|
Date |
2008-09-15
|
|
Type |
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion — |
|
Format |
application/pdf
|
|
Identifier |
http://journals.edizioniseed.it/index.php/FE/article/view/1010
10.7175/fe.v9i1S.1010 |
|
Source |
Farmeconomia. Health economics and therapeutic pathways; Vol 9, No 1S (2008); 55-57
2240-256X 1721-6915 |
|
Language |
eng
|
|
Relation |
http://journals.edizioniseed.it/index.php/FE/article/view/1010/1228
|
|